Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Expression of Ki67 and CD105 as Proliferation and Angiogenesis Markers in Salivary Gland Tumors

  • Tadbir, Azadeh Andisheh (Depatment of Oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences) ;
  • Pardis, Soheil (Depatment of Oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences) ;
  • Ashkavandi, Zohreh Jafari (Depatment of Oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences) ;
  • Najvani, Ali Dehghani (Depatment of Oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences) ;
  • Ashraf, Mohammad Javad (Department of Pathology, School of Medicine, Shiraz University of Medical Sciences) ;
  • Taheri, Ali (Dental School, Shiraz University of Medical Sciences) ;
  • Zadeh, Maryam Asad (Dental School, Shiraz University of Medical Sciences) ;
  • Sardari, Yasaman (Dental School, Shiraz University of Medical Sciences)
  • Published : 2012.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To investigate the association between CD105 and tumor cell proliferation in salivary gland tumors. Methods: In this study, 59 samples of salivary tumors from Khalili Hospital archive, including 20 cases of pleomorphic adenoma (PA), 20 cases of mucoepidermoid carcinoma (MEC) and 19 cases of adenoid cystic carcinoma, as well as 10 cases of normal salivary gland tissue, were reviewed by immunohistochemistry (IHC) for CD105 and Ki67 staining. Results: CD105 positive vessels were absent in normal salivary gland tissue in the vicinity of tumors (51.6% of all tumors were positive). There was a statistically significant difference in frequency of CD105 staining between PA and malignant tumors and between four groups of different lesions (p<0.000) being highest in MEC. Intratumoral microvessel density was also elevated in malignant neoplasms ($2.61{\pm}3.1$) as compared to PA ($0.46{\pm}0.6$). Normal salivary glands did not express Ki67. There was a statistically significant difference in frequency and percentage of Ki67 immunoreactivity in malignant neoplasms (86.5% and $10.7{\pm}10.8$ respectively) compared to PA (50% and $0.78{\pm}0.2$) and among the four groups values were highest in MEC (p<0.000). Conclusion: n this study, it was observed a higher rate of angiogenesis and cellular proliferation was noted in malignant tumors compared to benign tumors, but no correlation was observed between these two markers.

Keywords

References

  1. Ali AM, Ueno T, Tanaka S, et al (2011). Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients.Eur J Cancer, 47, 2265-72. https://doi.org/10.1016/j.ejca.2011.06.015
  2. Alves F, Pires F, de Almedia O, Lopes M, Kowalski L(2004). PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg, 33, 593-7. https://doi.org/10.1016/j.ijom.2004.01.010
  3. Barsky SH, Karlin NJ (2005). Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland BiolNeoplasia, 10, 249-260. https://doi.org/10.1007/s10911-005-9585-5
  4. Brewer CA, Setterdahl JJ, Li MJ, et al (2000). Endoglin expression as a measure of microvessel density in cervical cancer.Obstet gynecol, 96, 224-8. https://doi.org/10.1016/S0029-7844(00)00864-4
  5. Bullwinkel J, Baron-Luhr B, Ludemann A, Wohlenberg C, Gerdes J, Scholzen T(2006). Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol, 206, 624-35. https://doi.org/10.1002/jcp.20494
  6. Cardoso S, Souza K, Faria P, Eisenberg A, Dias F(2009). Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior. BMC Cancer, 9, 391-400. https://doi.org/10.1186/1471-2407-9-391
  7. Costa A, Demasi A, Bonritto V, et al(2008). Angiogenesis in salivary carcinomas with and without myoepithelial differentiation. Virchows Arch, 453, 359-67. https://doi.org/10.1007/s00428-008-0664-z
  8. Dallas NA, Samuel S, Xia L, et al (2008). Endoglin(CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res, 14, 1931-7. https://doi.org/10.1158/1078-0432.CCR-07-4478
  9. Duff SE, Li C, Garland JM, Kumar S (2003). CD105 is important for angiogenesis: evidence and potential applications. The FASEB J, 17, 984-91. https://doi.org/10.1096/fj.02-0634rev
  10. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M (2003). Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene, 22, 6557-63. https://doi.org/10.1038/sj.onc.1206813
  11. Fonseca I, Felix A, Soares J (1997). Cell proliferationin salivary gland adenocarcinomas with myoepithelial participation. Astudy of 78 cases. Virchows Arch, 430, 227-32. https://doi.org/10.1007/BF01324806
  12. Goumans MJ, Lebrin F, Valdimarsdottir G. Controlling the angiogenic switch (2003). Controlling the angiogenic switch:a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med,13,301-7. https://doi.org/10.1016/S1050-1738(03)00142-7
  13. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70. https://doi.org/10.1016/S0092-8674(00)81683-9
  14. Hillen F, Griffioen AW (2007). Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev, 26, 489-502. https://doi.org/10.1007/s10555-007-9094-7
  15. Hollstein M, Sidransky D, Volgelstein B, Harris C (1991).p53 mutations in human cancers. Science, 253, 49-53. https://doi.org/10.1126/science.1905840
  16. Kubota Y(2012). Tumor Angiogenesis and Anti-angiogenic Therapy.Keio J Med, 61, 47-56. https://doi.org/10.2302/kjm.61.47
  17. Lazzaro B, Cleveland D (2000). p53 and Ki-67 antigen expression in small oral biopsy specimens of salivary gland tumours. OralSurg Oral Med Oral PatholOralRadiolEndod,89, 613-617.
  18. Levi B, Wan DC, Glotzbach JP, et al (2011). CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of transforming growth factor β1 (TGF-β1) signaling. J Biol Chem, 286, 39497-509. https://doi.org/10.1074/jbc.M111.256529
  19. Liu P, Sun YL, Du J, Hou XS, Meng H (2012). CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer.Int J Gynecol Cancer, 22, 586-92. https://doi.org/10.1097/IGC.0b013e31823c36b8
  20. MacCallum DE, Hall PA (2000). The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol, 190,537-44. https://doi.org/10.1002/(SICI)1096-9896(200004)190:5<537::AID-PATH577>3.0.CO;2-W
  21. Meng CD, Zhu DD, Jiang XD, et al (2012). Overexpression of interleukin-l7 in tumor-associated macrophages is correlated with the differentiation and angiogenesis of laryngeal squamous cell carcinoma. Chin Med J (Engl), 125, 1603-7.
  22. Minhajat R, Mori D, Yamasaki F, et al (2006). Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int, 56, 717-23. https://doi.org/10.1111/j.1440-1827.2006.02037.x
  23. Nassiri F, Cusimano MD, Scheithauer BW, et al (2011). Endoglin(CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy.Anticancer Res, 31, 2283-90.
  24. Nguyen M, Lee MC, Wang JL,et al (2000). The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene, 19, 3449-59. https://doi.org/10.1038/sj.onc.1203677
  25. Nordgard S, Franzén G, Boysen M, Halvor.sen TB (1997). Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB 1 in paraffin sections. Laryngoscope, 107,531-6. https://doi.org/10.1097/00005537-199704000-00019
  26. Rahmanzadeh R, Hüttmann G, Gerdes J, Scholzen T (2007). Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis". Cell Prolif, 40, 422-3. https://doi.org/10.1111/j.1365-2184.2007.00433.x
  27. Romani AA, Borghetti AF, Del Rio P, Sianesi M, SolianiP (2006). The risk of developing metastatic disease in colorectal cancer is related to CD105-positive count. J SurgOncol, 93, 446-55
  28. Scalzo DA, Kallakury BV, Gaddipati RV,et al (1998). Cell proliferation rate by MIB-1 immunohistochemistry predicts postradiation recurrence in prostatic adenocarcinomas. Am J ClinPathol, 109, 163-8.
  29. Scholzen T, Gerdes J (2000). The Ki-67 protein: from the known and the unknown". J Cell Physiol, 182, 311-22. https://doi.org/10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
  30. Sharma S, Sharma MC, Sarkar C (2005). Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology, 46, 481-9. https://doi.org/10.1111/j.1365-2559.2005.02142.x
  31. Zijlmans HJ, Fleuren GJ, Hazelbag S, Sier CF, Dreef EJ, Kenter GG, Gorter A (2009). Expression of endoglin (CD105) in cervical cancer.Br J Cancer, 100, 1617-26. https://doi.org/10.1038/sj.bjc.6605009

Cited by

  1. MCM3 as a Novel Diagnostic Marker in Benign and Malignant Salivary Gland Tumors vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3479
  2. A New Method to Isolate and Culture Rat Kupffer Cells vol.8, pp.8, 2013, https://doi.org/10.1371/journal.pone.0070832
  3. Influence of Ribosomal Protein L39-L in the Drug Resistance Mechanisms of Lacrimal Gland Adenoid Cystic Carcinoma Cells vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4995
  4. Ki67 is a promising molecular target in the diagnosis of cancer (Review) pp.1791-3004, 2015, https://doi.org/10.3892/mmr.2014.2914
  5. Ki-67 is a Valuable Prognostic Factor in Gliomas: Evidence from a Systematic Review and Meta-analysis vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.411
  6. Expression of Ki67 in Papillary Thyroid Microcarcinoma and its Clinical Significance vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1605
  7. Angiogenesis in salivary gland tumors: from clinical significance to treatment vol.19, pp.6, 2015, https://doi.org/10.1517/14728222.2015.1016424
  8. Clinical implication of CD166 expression in salivary gland tumor vol.36, pp.4, 2015, https://doi.org/10.1007/s13277-014-2905-x
  9. Immunoexpression of hoxb7 and hoxb9 in salivary gland tumours vol.45, pp.9, 2016, https://doi.org/10.1111/jop.12438
  10. Repeated exposure to whole cigarette smoke promotes primary human gingival epithelial cell growth and modulates keratin expression vol.51, pp.5, 2016, https://doi.org/10.1111/jre.12343
  11. Ki-67 is overexpressed in human laryngeal carcinoma and contributes to the proliferation of HEp2 cells vol.12, pp.4, 2016, https://doi.org/10.3892/ol.2016.4980
  12. A Review of Selected Factors of Salivary Gland Tumour Formation and Malignant Transformation vol.2018, pp.2314-6141, 2018, https://doi.org/10.1155/2018/2897827
  13. The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator? vol.16, pp.1, 2018, https://doi.org/10.1186/s12957-018-1384-8